Denmark's Novo Nordisk, the world's largest maker of insulin, said first-quarter net profit rose 8%, though it cut its sales guidance for the full year.
from WSJ.com: US Business http://ift.tt/1rRmOPx
via IFTTT
from WSJ.com: US Business http://ift.tt/1rRmOPx
via IFTTT
No comments:
Post a Comment